Biotechnology company developing next-generation small-molecule therapeutics for serious diseases
Biotechnology company developing next-generation small-molecule therapeutics for serious diseases. Its Navigator platform combines synthetic biology, engineered human cells, high-throughput chemistry, automation, and AI/ML to discover drugs that modulate disease-driving cellular mechanisms, with programs in rare genetic disease, oncology, neurodegeneration, metabolism, and immunology.